 | Up a level |
Zlobec, I.; Helbling, M.; Dawson, Heather; Kölzer, V. H.; Diamantis Karamitopoulou, E.; Lugli, A. (2013). Hypermethylation of ZEB2 represents a novel mechanism of colorectal cancer progression and is a highly unfavourable prognostic factor in KRAS wild-type tumors. Virchows Archiv, 463(2), p. 139. Springer
Zlobec, I.; Helbling, M.; Dawson, Heather; Kölzer, V. H.; Karamitopoulou, E.; Lugli, A. (2013). ZEB2 CpG promoter methylation in colorectal cancer is associated with lymph node metastases and invasion in KRAS wild-type patients. Pathologe, 34(6), p. 592. Springer-Medizin-Verlag
Zlobec, I.; Helbling, M.; Karamitopoulou, E.; Dawson, Heather; Kölzer, V. H.; Lugli, A. (2013). CpG promoter hypermethylation of CTNNB1 (B-catenin) and TWIST2 promote a high-grade tumor budding phenotype in colorectal cancer. Pathologe, 34(6), p. 603. Springer-Medizin-Verlag
Kölzer, V. H.; Dawson, Heather; Karamitopoulou, E.; Lugli, A.; Zlobec, I. (2013). Loss of RKIP Expression in Colorectal Cancer Is Associated with Activation of the NF-kappa B Signaling Pathway and Epithelial-Mesenchymal Transition. Laboratory investigation, 93(S1), 161A-161A. Nature Publishing Group
Kölzer, V. H.; Dawson, Heather; Karamitopoulou, E.; Lugli, A.; Zlobec, I. (2013). Loss of RKIP Expression in Colorectal Cancer Is Associated with Activation of the NF-kappa B Signaling Pathway and Epithelial-Mesenchymal Transition. Modern pathology, 26(S2), 161A-161A. Nature Publishing Group 10.1038/modpathol.2013.9
